Louis Mauriac
Bordeaux, 33000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
Journal: British journal of cancer
Published: June 05, 2015
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria.
Journal: SpringerPlus
Published: January 22, 2015
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 07, 2014
Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making.
Journal: American journal of surgery
Published: February 15, 2013
Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes.
Journal: Radiology
Published: June 14, 2012
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity.
Journal: Breast cancer research and treatment
Published: December 07, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Journal: The Lancet. Oncology
Published: October 25, 2011
High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer.
Journal: British journal of cancer
Published: October 20, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026